[Skip to Navigation]
Comment & Response
July 2018

Additional Factors in Considering Patent Foramen Ovale Closure to Prevent Recurrent Ischemic Stroke—Reply

Author Affiliations
  • 1Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, Division of Stroke and Neurocritical Care, Department of Neurology, Weill Cornell Medical College, New York, New York
JAMA Neurol. 2018;75(7):895-896. doi:10.1001/jamaneurol.2018.1022

In Reply Powers raises several important issues that I did not address in detail in my Viewpoint1 about managing patent foramen ovale in patients with ischemic stroke. These additional points further highlight that many patients who are fully informed about the available data will reasonably choose medical therapy rather than patent foramen ovale closure.

Add or change institution